PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Significance: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA repair protein and part of the genome maintenance network. On the other hand, PARP-1 is involved in pathophysiological processes such as inflammation. Chronic inflammation has emerged as a key event in carcinogenesis, including the formation of colorectal cancer (CRC). Our data reveal that PARP-1 is abundantly expressed in human CRC, correlating with disease progression. Using transgenic mouse models, we show that PARP-1 fosters inflammation-driven colorectal tumor growth and stimulates the IL6-STAT3-cyclin D1 axis in tumors. In turn, PARP-1 protects against alkylation-triggered colorectal tumor induction dependent on the repair protein O 6 -methylguanine-DNA methyltransferase (MGMT). These findings unveil the opposing functions of PARP-1 in CRC initiation and CRC progression and its link to MGMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 1×
“STAT3, in turn, plays an important role in the maintenance of a procarcinogenic microenvironment in tumorigenesis, stimulates tumor cell proliferation, and inhibits antitumor immunity (34).”
BackgroundMolecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575 · cited 1×
“The AOM/DSS model was applied to induce DNA damage-initiated, inflammationdriven colorectal carcinogenesis (43).”
MethodCyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370 · cited 1×
“STAT3 has also been implicated in the expression of cyclin D1, which promotes cell proliferation and is overexpressed in human CRC (35).”
BackgroundDNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189 · cited 1×
“These include apoptosis and autophagy, which are both tumor-suppressive mechanisms (25), in particular at early stages of carcinogenesis.”
BackgroundSelf-citationPARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · cited 2×
“PARP-1 has a fundamental role in the maintenance of genome stability and regulates chromatin structure (6).”
BackgroundHigh resolution colonoscopy in live mice
Becker, C., Fantini, M. C., & Neurath, M. F. (2006) · Nature Protocols · doi:10.1038/nprot.2006.446 · Cited by 369
Haince, J.-F., Kozlov, S., Dawson, V. L., Dawson, T. M., Hendzel, M. J., Lavin, M. F., & Poirier, G. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608406200 · Cited by 261 · cited 1×
“PARP-1 is also engaged in lesion sensing by recruiting ATM and MRN to sites of DNA double-strand breaks (DSBs) and of stalled replication forks (12, 13).”
Background
Cited by
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
NAD+ metabolism, stemness, the immune response, and cancer
Navas, L. E., & Carnero, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00354-w · Cited by 517
Next-generation DNA damage sequencing
Mingard, C., Wu, J., McKeague, M., & Sturla, S. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00647e · Cited by 92
Self-citationNicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
Navas, L. E., & Carnero, A. (2022) · Cells · doi:10.3390/cells11172627 · Cited by 68
Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers
Alhusaini, A., Cannon, A., Maher, S. G., Reynolds, J. V., & Lynam-Lennon, N. (2021) · Biomedicines · doi:10.3390/biomedicines9081024 · Cited by 24
“At early stages, PARP1 is thought to play an anti-tumour role in CRC by repairing DNA damage that would otherwise result in mutagenesis [83].”
Background
Metadata
- Authors
- Dörsam, B., Seiwert, N., Foersch, S., Stroh, S., Nagel, G., Begaliew, D., Diehl, E., Kraus, A., McKeague, M., Minneker, V., Roukos, V., Reißig, S., Waisman, A., Moehler, M., Stier, A., Mangerich, A., Dantzer, F., Kaina, B., & Fahrer, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-04-09
- Volume
- 115
- Issue
- 17
- Pages
- E4061-E4070
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2797071790
- Cited by
- 105
- References
- 8
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression. https://app.cochat.ai/papers/10.1073/pnas.1712345115
- The paper
- Dörsam, B., Seiwert, N., Foersch, S., Stroh, S., Nagel, G., Begaliew, D., Diehl, E., Kraus, A., McKeague, M., Minneker, V., Roukos, V., Reißig, S., Waisman, A., Moehler, M., Stier, A., Mangerich, A., Dantzer, F., Kaina, B., & Fahrer, J. (2018). PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1712345115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.